Safety and food effects of VK4-116 for opioid use disorder
About this title
Read the official source — NCT06808932Understand this study
Who could participate?
This study is for healthy volunteers. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
- Listed locations
- Overland ParkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 48
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06808932
- Official title
Show the full official title
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study With Food-Effect Cohort to Assess the Safety, Tolerability, and Pharmacokinetics of Oral (R) VK4-116 in Healthy Volunteers
Recruitment & locations
Overland Park
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including VK4-116 and Placebo.
Who can participate?
This study is for healthy volunteers. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
